A Phase 2/3 interventional study of Ivermectin in COVID, sponsored by Tanta University. Recruiting at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2021-03-10.
Sponsored by Tanta University · Phase 2/3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Efficacy of Ivermectin in larger doses in COVID-19 treatment
Clinical Study Evaluating the Efficacy of Ivermectin in higher doses in COVID-19 treatment
Tanta University is the lead sponsor of 1,015 studies on the registry; 321 are open to participants now.
Of its 15 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Ivermectin alone in larger doses
Drug: Ivermectin
Standard of care treatment
ivermectin
Number of patients with improvement or died
The number of patients with improvement or death
Time frame: 1 month
Plan to share: No
No publications or documents are linked to this record.
Started Jun 2020 (actual). Primary completion is estimated for Dec 2030, 125 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ivermectin